TETRA Technologies Inc.
TTI | NYSE
$6.07
-$0.02 (-0.33%)
Sep 22, 2026, 2:36 PM ET · Market open
Company Profile
TETRA Technologies, Inc. (TTI) is a diversified enterprise that delivers a range of services to the oil and gas industry. The company organizes its operations into two primary divisions: Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products segment is responsible for the production and distribution of specialized chemical formulations, such as clear brine fluids, various additives, and complementary services. These products are vital for well drilling, completion, and workover procedures in the oil and gas sector, with a market presence spanning the United States, Latin America, Europe, Asia, the Middle East, and Africa. This division also trades in both liquid and dry calcium chloride products. The Water & Flowback Services segment offers comprehensive water management solutions designed for onshore oil and gas operators. Additionally, it provides services like frac flowback and production well testing, along with other related support. These services are delivered across oil and gas producing areas in the United States and Mexico, as well as in numerous basins throughout Latin America, Africa, Europe, and the Middle East. Founded in 1981, TETRA Technologies, Inc. is headquartered in The Woodlands, Texas.
Key Executives
| Name | Position |
|---|---|
| Brady Murphy | President, Chief Executive Officer & Director |
| Alicia Boston | Senior Vice President, General Counsel & Chief Compliance Officer |
| Katherine Kokenes | VP & Chief Accounting Officer |
| Kimberly O'Brien | Corporate Secretary |
| Kurt Kevin Hallead | Treasurer & Vice President of Investor Relations |
| Matthew J. Sanderson | Executive VP & CFO |
| Roy Evan McNiven | Senior Vice President of Energy Services Operations |
| Timothy C. Moeller | Senior Vice President of Global Supply Chain & Chemicals |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 02, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 04, 2026 | 10-Q | Quarterly Report |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 02, 2026 | 4 | Filing |
| Jun 23, 2026 | 11-K | Filing |
TETRA Technologies Inc.
| Country | United States |
| IPO Date | Apr 2, 1990 |
| Industry | Oil & Gas Equipment & Services |
| Sector | Energy |
| Employees | 1,400 |
| CEO | Brady Murphy |
Contact Details
10000 Energy Drive Spring,
Texas 77389 United States
Stock Details
| Ticker Symbol | TTI |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000844965 |
| CUSIP Number | 88162F105 |
| ISIN Number | US88162F1057 |
| SIC Code | 1311 |
Recent News
- 1 month ago / seekingalpha.comTvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript
- 2 months ago / zacks.comTetra Technologies (TTI) Reports Q2 Earnings: What Key Metrics Have to Say
- 2 months ago / seekingalpha.comTETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript
- 2 months ago / zacks.comTetra Technologies (TTI) Q2 Earnings Meet Estimates
- 2 months ago / zacks.comCompared to Estimates, Tetra Technologies (TTI) Q2 Earnings: A Look at Key Metrics
- 2 months ago / prnewswire.comTETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS
- 2 months ago / globenewswire.comTvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
- 2 months ago / zacks.comTetra Technologies (TTI) to Report Q2 Results: What to Know Ahead of the Release
- 2 months ago / prnewswire.comTETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS CONFERENCE CALL
- 2 months ago / newsfilecorp.comThiogenesis Receives FDA Rare Pediatric Disease Designation for TTI-0102 for the Treatment of Leigh Syndrome
Add to Watchlist
Select watchlists to add or remove TTI